Biopharma Manufacturers Transcept Pharmaceuticals (Point Richmond, CA) has appointed John Kollins as senior vice president and chief business officer. Previously, he was associated with Parnassus Partners, and before that, CEO of Oxigene. Transcept is developing neuroscience products, including its first […]
Read MoreThe pharmaceutical industry routinely recruits medical doctors (MDs) and researchers from academia, which serves as something of a farm system for the industry. Most of these scientists move into research or medical affairs roles when they join industry. Some of […]
Read MorePharma is eagerly responding to Apple’s iPad. Does this make sense? Yes. And no. Does it make sense for your company to invest in iPads now? What factors should drive your decision? If you decide to jump in, how can […]
Read MoreIs there life after the lab? That’s a question that I’ve heard from clients over and over during the last half-dozen years or so. Many pharmaceutical executives have pondered that question and I’m sure scores more are pondering it today. […]
Read MoreNew Jersey is known as the Mecca of the pharmaceutical industry in North America and is home to 15 of the world’s 20 largest pharmaceutical companies. In 2009, the industry pumped $28.7 billion into the New Jersey economy. Just to […]
Read MoreThere has probably never been as inauspicious a time to produce a multi-year projection of US employment as December 2009, when the overall economic conditions, the political scene in Washington, and populist unrest have combined to make the high unemployment […]
Read MoreHere’s what executives need to know about marketing regulations: compliance is core to the very culture of your company. Underestimate its importance at your peril. The training of executives on marketing compliance is an art form all its own. The […]
Read MorePfizer is positioning its senior management following the merger with Wyeth Pharmaceuticals. As laid out by CEOs Jeff Kindler and Bernard Poussot, it will form two distinct research organizations, PharmaTherapeutics Research Group for small molecules, and BioTherapeutics Research Group, for […]
Read MoreCMR Institute (Roanoke, VA), the only nationally recognized training program for certifying medical representatives and managers, has developed a new training program called 4C (for “Core Competencies, Capabilities and Credibility”). It is an addition to the Institute’s programs for certified […]
Read MoreMark Altmeyer is now president and CEO of Otsuka American Pharmaceutical, Inc., (Rockville, MD and Princeton, NJ) replacing Dean R. Haubrich, who will now be chairman of the board. Altmeyer joins Otsuka from Bristol Myers Squibb, where he was SVP, […]
Read More
